Southey M - Search Results

1

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.

Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T; BCAC Consortium; Wang Q, Bolla MK, Dennis J, Michailidou K, Lush M, Ahearn T, Andrulis IL, Anton-Culver H, Antoniou AC, Arndt V, Augustinsson A, Auvinen P, Beane Freeman L, Beckmann M, Behrens S, Bermisheva M, Bodelon C, Bogdanova NV, Bojesen SE, Brenner H, Byers H, Camp N, Castelao J, Chang-Claude J, Chirlaque MD, Chung W, Clarke C; NBCS Collaborators; Collee MJ, Colonna S; CTS Consortium; Couch F, Cox A, Cross SS, Czene K, Daly M, Devilee P, Dork T, Dossus L, Eccles DM, Eliassen AH, Eriksson M, Evans G, Fasching P, Fletcher O, Flyger H, Fritschi L, Gabrielson M, Gago-Dominguez M, García-Closas M, Garcia-Saenz JA, Genkinger J, Giles GG, Goldberg M, Guénel P, Hall P, Hamann U, He W, Hillemanns P, Hollestelle A, Hoppe R, Hopper J; ABCTB Investigators; Jakovchevska S, Jakubowska A, Jernström H, John E, Johnson N, Jones M, Vijai J, Kaaks R, Khusnutdinova E, Kitahara C, Koutros S, Kristensen V, Kurian AW, Lacey J, Lambrechts D, Le Marchand L, Lejbkowicz F, Lindblom A, Loibl S, Lori A, Lubinski J, Mannermaa A, Manoochehri M, Mavroudis D, Menon U, Mulligan A, Murphy R, Nevelsteen I, Newman WG, Obi N, O'Brien K, Offit K… See abstract for full author list ➔ Levi H, et al. Among authors: southey m. J Med Genet. 2023 Nov 27;60(12):1186-1197. doi: 10.1136/jmg-2023-109185. J Med Genet. 2023. PMID: 37451831 Free PMC article.

2

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.

Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G. Spurdle AB, et al. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):413-6. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927503

3

The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G. Spurdle AB, et al. Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):439-43. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12010857

4

Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.

Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, Godwin AK, Hopper JL, Li F, Neuhausen SL, Ozcelik H, Peel D, Santella RM, Southey MC, van Orsouw NJ, Venter DJ, Vijg J, Whittemore AS; Cooperative Family Registry for Breast Cancer studies. Andrulis IL, et al. Among authors: southey mc. Hum Mutat. 2002 Jul;20(1):65-73. doi: 10.1002/humu.10097. Hum Mutat. 2002. PMID: 12112659

5

After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families.

Jenkins MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, Mead LJ, St John DJ, Macrae FA, Bishop DT, Venter DJ, Giles GG, Hopper JL. Jenkins MA, et al. Int J Cancer. 2002 Nov 10;102(2):166-71. doi: 10.1002/ijc.10670. Int J Cancer. 2002. PMID: 12385013 Free article.

6

Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics.

Scott CL, Jenkins MA, Southey MC, Davis TA, Leary JA, Easton DF, Phillips KA, Hopper JL. Scott CL, et al. Hum Genet. 2003 May;112(5-6):542-51. doi: 10.1007/s00439-003-0908-6. Epub 2003 Feb 25. Hum Genet. 2003. PMID: 12601471

7

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL. Dite GS, et al. J Natl Cancer Inst. 2003 Mar 19;95(6):448-57. doi: 10.1093/jnci/95.6.448. J Natl Cancer Inst. 2003. PMID: 12644538

8

Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.

Cui JS, Spurdle AB, Southey MC, Dite GS, Venter DJ, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL. Cui JS, et al. Genet Epidemiol. 2003 Apr;24(3):161-72. doi: 10.1002/gepi.10222. Genet Epidemiol. 2003. PMID: 12652520

9

ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.

Severi G, Giles GG, Southey MC, Tesoriero A, Tilley W, Neufing P, Morris H, English DR, McCredie MR, Boyle P, Hopper JL. Severi G, et al. J Natl Cancer Inst. 2003 Jun 4;95(11):818-24. doi: 10.1093/jnci/95.11.818. J Natl Cancer Inst. 2003. PMID: 12783937

10

The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.

Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. Montgomery KG, et al. Among authors: southey mc. Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1109-11. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14578152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

727 results

Search Page